Lisanti Capital Growth, LLC Neurocrine Biosciences Inc Transaction History

Lisanti Capital Growth, LLC

$344 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$130.4 - $143.74 $13,692 - $15,092	-105 Reduced 1.55%	6,650 $917,000
Q4 2023 Feb 06, 2024	SELL	$106.07 - $132.76 $2.11 Million - $2.64 Million	-19,875 Reduced 74.63%	6,755 $890,000
Q3 2023 Nov 02, 2023	BUY	$94.02 - $117.1 $1.23 Million - $1.53 Million	13,040 Added 95.95%	26,630 $3 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $1.22 Million - $1.43 Million	13,590 New	13,590 $1.28 Million
Q4 2022 Feb 03, 2023	SELL	$106.72 - $127.06 $6.2 Million - $7.38 Million	-58,055 Reduced 66.46%	29,295 $3.5 Million
Q3 2022 Nov 01, 2022	BUY	$92.03 - $107.81 $2.85 Million - $3.34 Million	31,000 Added 55.01%	87,350 $9.28 Million
Q2 2022 Aug 03, 2022	BUY	$75.79 - $100.07 $1.07 Million - $1.41 Million	14,140 Added 33.5%	56,350 $5.49 Million
Q1 2022 May 12, 2022	BUY	$72.45 - $94.81 $3.06 Million - $4 Million	42,210 New	42,210 $3.96 Million
Q3 2020 Nov 05, 2020	SELL	$96.16 - $135.15 $1.47 Million - $2.07 Million	-15,315 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$85.09 - $130.36 $478,205 - $732,623	5,620 Added 57.97%	15,315 $1.87 Million
Q1 2020 May 11, 2020	SELL	$75.11 - $113.76 $55,656 - $84,296	-741 Reduced 7.1%	9,695 $839,000
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $118,568 - $161,966	1,366 Added 15.06%	10,436 $1.12 Million
Q3 2019 Nov 06, 2019	BUY	$83.82 - $101.5 $760,247 - $920,605	9,070 New	9,070 $817,000
Q4 2018 Feb 08, 2019	SELL	$68.32 - $124.36 $486,438 - $885,443	-7,120 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$98.88 - $125.85 $10,876 - $13,843	-110 Reduced 1.52%	7,120 $875,000
Q2 2018 Aug 13, 2018	SELL	$75.3 - $105.99 $299,317 - $421,310	-3,975 Reduced 35.48%	7,230 $710,000
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $208,670 - $254,182	2,750 Added 32.53%	11,205 $929,000
Q4 2017 Feb 07, 2018	BUY	$58.53 - $77.59 $494,871 - $656,023	8,455	8,455 $656,000

Others Institutions Holding NBIX

# of Institutions

635

Shares Held

93.5M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.09 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.48 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$760 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$380 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$275 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Account